Curis, Inc. (CRIS)
0.915
+0.09
(+10.67%)
USD |
NASDAQ |
Jan 12, 16:00
0.89
-0.02
(-2.73%)
After-Hours: 20:00
Curis Research and Development Expense (Quarterly): 6.432M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 0.525M |
| Perspective Therapeutics, Inc. | 19.56M |
| Protalix Biotherapeutics, Inc. | 4.467M |
| Electromed, Inc. | 0.241M |
| Armata Pharmaceuticals, Inc. | 5.824M |